Background: Vitamin D is an important factor responsible for many physiologic functions. Vitamin D deficiency is associated with increased risk of neurodegenerative disease. The level of vitamin D in Iranian patients with Parkinson's disease and its relationship with severity of symptoms and signs were evaluated in this study. Methods: Eighty-three patients with Parkinson's disease (PD) were recruited using simple non-random sampling. 25-hydroxyvitamin D [25(OH)D3] was measured by Electrochemiluminescence immunoassay (ECLIA). Serum level of calcium and phosphorus was measured to exclude other endocrine disorders. Results: The mean 25(OH)D3 concentration was lower in the PD population than in the normal group. Lower levels of 25(OH)D3 were associated with more severe postural instability and abnormal posture. There was no significant association between levels of 25(OH)D3 and severity of other symptoms of parkinsonism. Conclusion: This analysis showed that serum 25(OH)D levels are lower in PD patients in comparison with normal range. In addition, there was a significant association between the presences of freezing, postural instability and abnormal postures with lower levels of 25(OH)D.
Introduction
Vitamin D has an important role in many physiologic functions; moreover, vitamin D deficiency is associated with increased risk of several types of cancers, as well as autoimmune and cardiovascular disorders. [1] [2] [3] Vitamin D functions include perseveration of mineral bone density, muscle strength and innate immunity. 1, 2 Indeed, vitamin D is necessary for regulation of some neurodegenerative processes such as neurotrophin, inducible nitric oxide synthase (iNOS), glutathione and monoamine synthesis and also apoptosis. 4, 5 These mechanisms are probable pathogenesis of some neurodegenerative diseases such as multiple sclerosis (MS) and Parkinson's disease (PD). 6 Given the expression of both 1-hydroxylase (1-OHase) and vitamin receptors (VDRs) in many extra renal tissues -including muscle and brain -vitamin D status may be important for prevention or treating neurodegenerative disorders. 7, 8 In brain, hippocampus and substantia nigra neurons demonstrate high concentrations of VDRs in their nucleus and 1-OHase in their cytosol. Some previous investigations concerning vitamin D deficiency in PD focused on skeletal health associations in old Asian populations. [9] [10] [11] [12] Besides, epidemiologic, animal, and human data supported that vitamin D deficiency may be involved in the pathogenesis, progression, and clinical manifestations of PD. 6 Parkinson's disease (PD) is a movement disorder and is one of the most common causes of disability in 9, [15] [16] [17] In this study, the association of serum vitamin D concentration and PD symptoms severity were reviewed.
Materials and Methods
The study was approved by the Medical Ethics Committee of Tehran University of Medical Sciences. Patients Eighty-three PD subjects, who referred to Neurology Clinic of Rasoul-e-Akram Hospital (affiliated to Tehran University of Medical Sciences, Iran), were randomly recruited in the study. Informed consent was obtained from all the subjects before the intervention. Diagnosis of PD was confirmed with comorbidity of abnormal movement disorders.
The patients filled out a questionnaire about their demographic characteristics (age, sex, etc.), duration of illness, initial symptom, comorbidity and last time of medication consumption. Physical examination was done by a neurologist; the scores are shown in table 1.
Laboratory Tests
Blood samples (4cc) were taken through an intravenous cannula inside the forearm and were transferred to the laboratory in cold boxes.
Serums were analyzed for 25(OH)D3 concentration with Electrochemiluminescence immunoassay (ECLIA). Serum level of calcium, phosphorus and PTH were also assessed for Hypokinesia-bradykinesia 36.1% (30 patients), and rigidity 1.2% (1 patient) were other initial symptoms. The mean 25(OH)D level was 17.60 ± 16.89 ng/ml (range 4-98 ng/ml) (normal range of 16-40 ng/ml). There was a significant difference between 25(OH)D of PD patients compared to the normal range of 25(OH)D (P < 0.01) and levels of 25(OH)D according to the seasons of sampling.
25(OH)D levels were significantly higher in spring in comparison with summer and fall seasons (P < 0.01). There was no significant changes between 25(OH)D levels in summer sampling and fall sampling (P = 0.60) ( Table 2) .
There was no significant difference in 25(OH)D levels between males and females (17.82 ± 17.85 ng/ml vs. 16.91 ± 13.84 ng/ml) (P = 0.93). 25(OH)D levels were increased with age increase (r = 0.2).
There was a significant difference between 25(OH)D levels in patients younger than 50 years compared to the older ones (10.92 ± 11.03 vs. 20.16 ± 18.09 ng/ml) (P = 0.02). There was a reverse association between duration of disease and 25(OH)D levels (r = -0.1).
Our analysis showed no significant association between 25(OH)D levels and initial symptom of the disease (P = 0.28), severity of resting tremor (P = 0.5), bradykinesia/hypokinesia (P = 0.10) and chills (P = 0.7).
There was a major association between 25(OH)D levels and severity of postural instability (P = 0.05), impaired posture (P = 0.02) and presence or absence of freezing(14.01 ± 14.09 vs. 25.48 ± 19.94 ng /ml) (P < 0.01) ( Table 3) .
Discussion
Vitamin D deficiency is an important condition in the elderly. Prevalence of neurodegenerative disease is also higher in these patients. Vitamin D is produced in body in skin on exposure to UV-B radiation and is found in limited food sources. 1, 18 Some involved factors in vitamin D deficiency are advanced age, obesity, avoidance of sun exposure, residence in northerly latitudes, and darker skin. Patients with PD have many risk factors for vitamin D deficiency such as advanced age, immobility and activation due to chills or abnormal posture and malnutrition. Serum 25(OH)D is the most useful indicator of vitamin D level of body. 19 It is derived from both dietary intake and sunlightinduced production by the skin. 20 In our study, mean 25(OH)D level was lower in comparison with previous studies. In the study of Evatt et al. 21 in Atlanta, the mean 25(OH)D levels was 31.9 ± 13.6 which was significantly higher than our patients. It is probably due to differences between geographical latitude, sun radiation, coating conditions and amount of skin pigmentation.
In our study, results suggested that serum 25(OH)D levels were lower in PD patients in In the study of Sato et al., the higher incidence of nonvertebral fractures was seen in female patients with PD that might be due to frequent falls and osteoporosis caused by deficiency of vitamins D. 22 Supplementation of vitamin D and increased sun exposure may improve the quality of life of patients with Parkinson's disease and decrease complications such as falling and fractures.
Sato et al. examined elderly patients who were immobilized chronically from PD to assess the effect of sun shining in the development of hip and vertebral fractures. 23 The high incidence of hip fractures in elderly PD patients might be attributed to the frequent falls and osteoporosis due to vitamin D deficiency. A recent study suggested that vitamin D supplementation reduced the risk of falls among ambulatory or institutionalized older individuals. 23 In conclusion, this analysis showed that serum 25(OH)D levels were lower in PD patients in comparison with normal range. Moreover, there was a significant associations between the presence of chills, postural instability and abnormal postures with lower levels of 25(OH)D.
Limitations of the present study were lack of controlling dietary intake and exposure to sunlight, and also the portion of plasma samples drawn in the spring and fall to summer were not matched with each other.
